Amgen 
Welcome,         Profile    Billing    Logout  
 160 Products   813 Diseases   160 Products   1618 Trials   78436 News 


«12...879880881882883884885886887888889...910911»
  • ||||||||||  Prolia (denosumab) / Amgen, Daiichi Sankyo
    New P3 trial:  Denosumab China Phase III Study (clinicaltrials.gov) -  Dec 16, 2013   
    P3,  N=444, Recruiting, 
  • ||||||||||  Prolia (denosumab) / Amgen, Daiichi Sankyo
    Trial initiation date:  Observational Study of Denosumab (Prolia (clinicaltrials.gov) -  Dec 15, 2013   
    P=N/A,  N=1501, Active, not recruiting, 
    Active, not recruiting --> Completed Initiation date: Nov 2011 --> Nov 2012
  • ||||||||||  Prolia (denosumab) / Amgen, Daiichi Sankyo
    Enrollment change:  Observational Study of Denosumab (Prolia (clinicaltrials.gov) -  Dec 15, 2013   
    P=N/A,  N=1501, Active, not recruiting, 
    N=168 --> 120 N=1200 --> 1501
  • ||||||||||  Prolia (denosumab) / Amgen, Daiichi Sankyo
    Enrollment closed:  Observational Study of Denosumab (Prolia (clinicaltrials.gov) -  Dec 15, 2013   
    P=N/A,  N=1501, Active, not recruiting, 
    N=1200 --> 1501 Recruiting --> Active, not recruiting
  • ||||||||||  Enbrel (etanercept) / Pfizer, Amgen
    Enrollment closed, HEOR:  Observational Study Evaluating Etanercept (Enbrel (clinicaltrials.gov) -  Dec 15, 2013   
    P=N/A,  N=800, Active, not recruiting, 
    Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
  • ||||||||||  Simulect (basiliximab) / Novartis, Enbrel (etanercept) / Pfizer, Amgen, Zinbryta (daclizumab) / Biogen, AbbVie
    Trial completion:  Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes (clinicaltrials.gov) -  Dec 15, 2013   
    P2,  N=14, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  AMG 337 / ImmunityBio, Amgen
    Enrollment change, Metastases:  A Study of AMG 337 in Subjects With Advanced Solid Tumors (clinicaltrials.gov) -  Dec 9, 2013   
    P1,  N=149, Recruiting, 
    Enrolling by invitation --> Active, not recruiting N=119 --> 149
  • ||||||||||  Neupogen (filgrastim) / Kyowa Kirin, Amgen
    Enrollment closed, Combination therapy:  Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers (clinicaltrials.gov) -  Dec 5, 2013   
    P2,  N=108, Active, not recruiting, 
    Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
  • ||||||||||  trebananib (AMG 386) / Amgen
    Enrollment change:  AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2) (clinicaltrials.gov) -  Dec 4, 2013   
    P3,  N=223, Active, not recruiting, 
    Recruiting --> Active, not recruiting N=380 --> 223
  • ||||||||||  trebananib (AMG 386) / Amgen
    Enrollment closed:  AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2) (clinicaltrials.gov) -  Dec 4, 2013   
    P3,  N=223, Active, not recruiting, 
    N=380 --> 223 Recruiting --> Active, not recruiting